Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab (Q44597034)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab |
scientific article published in January 2013 |
Statements
1 reference
Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab (English)
1 reference
Hugo Vanderstichele
1 reference
D Richard Lachno
1 reference
Barbara A Evert
1 reference
Michael Robertson
1 reference
Ronald B Demattos
1 reference
Robert J Konrad
1 reference
Jayne A Talbot
1 reference
Margaret M Racke
1 reference
Robert A Dean
1 reference
1 January 2013
1 reference
1 reference
34
1 reference
4
1 reference
897-910
1 reference
Identifiers
1 reference
1 reference